144 related articles for article (PubMed ID: 26563255)
21. Knowledge and Attitudes of Women towards Human Papilloma Virus and HPV Vaccine in Thulamela Municipality of Vhembe District in Limpopo Province, South Africa.
Ramathuba DU; Ngambi D
Afr J Reprod Health; 2018 Sep; 22(3):111-119. PubMed ID: 30381938
[TBL] [Abstract][Full Text] [Related]
22. Cancer burden and control in the Western Pacific region: challenges and opportunities.
Varghese C; Carlos MC; Shin HR
Ann Glob Health; 2014; 80(5):358-69. PubMed ID: 25512151
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
24. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.
Hutubessy R; Levin A; Wang S; Morgan W; Ally M; John T; Broutet N
BMC Med; 2012 Nov; 10():136. PubMed ID: 23146319
[TBL] [Abstract][Full Text] [Related]
25. Role of VIA in cervical cancer screening in low-resource countries.
Nahar KN; Nessa A; Shamim S; Nasrin B; Hossain F; Begum N
Mymensingh Med J; 2011 Jul; 20(3):528-35. PubMed ID: 21804524
[TBL] [Abstract][Full Text] [Related]
26. Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.
Praditsitthikorn N; Teerawattananon Y; Tantivess S; Limwattananon S; Riewpaiboon A; Chichareon S; Ieumwananonthachai N; Tangcharoensathien V
Pharmacoeconomics; 2011 Sep; 29(9):781-806. PubMed ID: 21838332
[TBL] [Abstract][Full Text] [Related]
27. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.
Mapanga W; Girdler-Brown B; Feresu SA; Chipato T; Singh E
Syst Rev; 2018 Nov; 7(1):198. PubMed ID: 30447695
[TBL] [Abstract][Full Text] [Related]
28. Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.
Woodring J; Pastore R; Brink A; Ishikawa N; Takashima Y; Tohme RA
MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(8):195-200. PubMed ID: 30817746
[TBL] [Abstract][Full Text] [Related]
29. Latin American and the Caribbean Code Against Cancer 1st edition: Infections and cancer.
Herrero R; Carvajal LJ; Camargo MC; Riquelme A; Porras C; Ortiz AP; Camargo LA; Fink V; van De Wyngard V; Lazcano-Ponce E; Canelo-Aybar C; Balbin-Ramon G; Feliu A; Espina C
Cancer Epidemiol; 2023 Oct; 86 Suppl 1():102435. PubMed ID: 37852729
[TBL] [Abstract][Full Text] [Related]
30. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
31. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
32. The prevention of cervical cancer in Africa.
Fiander AN
Womens Health (Lond); 2011 Jan; 7(1):121-32. PubMed ID: 21175396
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women.
Llanos AAM; Tsui J; Rotter D; Toler L; Stroup AM
BMC Womens Health; 2018 Oct; 18(1):162. PubMed ID: 30285820
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
35. Modelling the impact of prevention strategies on cervical cancer incidence in South Africa.
van Schalkwyk C; Moodley J; Welte A; Johnson LF
Int J Cancer; 2021 Oct; 149(8):1564-1575. PubMed ID: 34164807
[TBL] [Abstract][Full Text] [Related]
36. Cervical and anal cancer prevention in jails and prisons: "A missed opportunity": Although cancers linked to the human papillomavirus are preventable through vaccination and screening, these protective measures largely have been overlooked in correctional health care systems.
Nelson B
Cancer Cytopathol; 2020 Apr; 128(4):227-228. PubMed ID: 32251554
[No Abstract] [Full Text] [Related]
37. Population attributable fraction of infection-related cancers in Korea.
Shin A; Park S; Shin HR; Park EH; Park SK; Oh JK; Lim MK; Choi BY; Boniol M; Boffetta P
Ann Oncol; 2011 Jun; 22(6):1435-1442. PubMed ID: 20974652
[TBL] [Abstract][Full Text] [Related]
38. Cancers attributable to infections in Canada.
Volesky KD; El-Zein M; Franco EL; Brenner DR; Friedenreich CM; Ruan Y;
Prev Med; 2019 May; 122():109-117. PubMed ID: 31078164
[TBL] [Abstract][Full Text] [Related]
39. Clinical cancer chemoprevention: From the hepatitis B virus (HBV) vaccine to the human papillomavirus (HPV) vaccine.
Tsai HJ
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):112-5. PubMed ID: 25951712
[TBL] [Abstract][Full Text] [Related]
40. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
